Systemic administration of sodium azide, a selective inhibitor of the
mitochondrial enzyme cytochrome oxidase, has been reported to produce
deficits in memory and long-term potentiation (Bennett, Diamond, Stryk
er, Parks, & Parker, 1992; Bennett & Rose, 1992). We have further char
acterized the memory deficits observed during the period of infusion o
f this toxin and have evaluated learning and memory following the term
ination of infusions to assess the permanence of deficits. In addition
, the brains of sodium-azide-infused rats were examined histologically
to evaluate neuropathological changes that might accompany the learni
ng deficits. We confirmed the deficit in water-maze acquisition observ
ed previously during sodium-azide infusion (Bennett & Rose, 1992) but
found that azide-infused animals were as capable as vehicle-infused an
imals of remembering the platform location once they had learned it. I
n addition, during sodium-azide infusion, we found a short-term passiv
e-avoidance retention deficit that slowly improved with longer delays.
Sodium-azide-infused animals showed deficits in water-maze reversal r
etention shortly after the infusion was terminated, but they recovered
by 6 months postinfusion. No significant locomotor differences were d
etected between azide- and vehicle-infused animals, but a significant
fine sensorimotor deficit was detected during azide infusion. Histolog
ical analyses revealed no obvious neuronal cell loss after sodium-azid
e infusion, but rather a loss of myelinated fiber staining in the retr
osplenial (posterior cingulate) cortex. The sodium-azide-infused rat m
ay thus serve as an animal model of learning deficits resulting from m
etabolic and structural alterations in the Limbic cortex.